scPharmaceuticals Inc. (SCPH) Debt-to-equity % [USD] 2018 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
scPharmaceuticals Inc. quarterly Debt-to-equity history and growth rate from 2018 to 2024.
  • scPharmaceuticals Inc. Debt-to-equity for the quarter ending March 31, 2024 was 126 %, a 98% increase year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 126 +62.1 +98% Mar 31, 2024
Q4 2023 96 +40.5 +73.1% Dec 31, 2023
Q3 2023 80.9 +36.9 +83.9% Sep 30, 2023
Q2 2023 70.6 +29.9 +73.5% Jun 30, 2023
Q1 2023 63.4 +25.1 +65.7% Mar 31, 2023
Q4 2022 55.5 +19 +52.1% Dec 31, 2022
Q3 2022 44 +9.27 +26.7% Sep 30, 2022
Q2 2022 40.7 +8.02 +24.6% Jun 30, 2022
Q1 2022 38.3 +7.97 +26.3% Mar 31, 2022
Q4 2021 36.5 +4.1 +12.7% Dec 31, 2021
Q3 2021 34.7 -0.71 -2% Sep 30, 2021
Q2 2021 32.7 -7.72 -19.1% Jun 30, 2021
Q1 2021 30.3 -13.6 -31.1% Mar 31, 2021
Q4 2020 32.4 -5.42 -14.3% Dec 31, 2020
Q3 2020 35.4 +5.5 +18.4% Sep 30, 2020
Q2 2020 40.4 +17.5 +76.7% Jun 30, 2020
Q1 2020 43.9 +24 +120% Mar 31, 2020
Q4 2019 37.8 +19.9 +111% Dec 31, 2019
Q3 2019 29.9 +13 +76.9% Sep 30, 2019
Q2 2019 22.8 Jun 30, 2019
Q1 2019 19.9 Mar 31, 2019
Q4 2018 17.9 Dec 31, 2018
Q3 2018 16.9 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.